A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer

Jia-Lin Lee, Y-K. Kang, Hye Jin Kang, +12

British Journal of Cancer

LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study

Narikazu Boku, M.-H. Ryu, D-Y. Oh, +16

Annals of Oncology

Chemotherapy Versus ChemotherapyGastrointestinal OncologyMedicineGastroenterologyPathology +6

Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum

Dok Hyun Yoon, M.-H. Ryu, Y S Park, +7

British Journal of Cancer

Pertuzumab (P) + trastuzumab (H) + chemotherapy (CT) for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (mGC/GEJC): Final analysis of a Phase III study (JACOB)

Josep Tabernero, Paulo M. Hoff, Lin Shen, +7

Annals of Oncology

Her2-positive Metastatic GastricGastrointestinal OncologyMedicineGastroenterologyPathology +6

Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib

Y-K. Kang, Changhoon Yoo, B-Y. Ryoo, +8

British Journal of Cancer

Expression of mdr-1 in refractory lymphoma: quantitation by polymerase chain reaction and validation of the assay [published erratum appears in Blood 1995 Dec 15;86(12):4710]

Y-K. Kang, Zhiqing Zhan, Joanna Regis, +6

Blood

ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF

Jia-Lin Lee, Sung‐Min Kim, S W Kim, +10

Bone Marrow Transplantation

Hematological MalignancyLymphoid NeoplasiaPretreated Non-hodgkinMedicineMalignant Blood Disorder +8

Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy

H. Kang, Heung-Moon Chang, Tae‐Won Kim, +7

British Journal of Cancer

A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer

H. Kang, Heung-Moon Chang, T W Kim, +7

British Journal of Cancer

HER2-positive advanced gastric cancer: similar HER2-positivity levels to breast cancer

Florian Lordick, Y. Bang, Y-K. Kang, +7

mediaTUM (Technical University of Munich)

Breast OncologyGastrointestinal OncologySimilar Her2-positivity LevelsMedicineGastroenterology +6